Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jun 9;35(23):3027-36.
doi: 10.1038/onc.2015.358. Epub 2015 Oct 5.

Exosomes mediate the acquisition of the disease phenotypes by cells with normal genome in tuberous sclerosis complex

Affiliations

Exosomes mediate the acquisition of the disease phenotypes by cells with normal genome in tuberous sclerosis complex

B Patel et al. Oncogene. .

Abstract

Functions of extracellular vesicles including exosomes in the pathogenesis of tuberous sclerosis complex (TSC) have not yet been studied. We report that the extracellular vesicles such as exosomes derived from tuberous sclerosis 1 (Tsc1)-null cells transform phenotypes of neighboring wild-type cells in vivo in such manner that they become functionally similar to Tsc1-null cells. The loss of Tsc1 in the mouse neural tube increases the number of the wild-type neuronal progenitors, which is followed by the precocious and transient acceleration of neuronal differentiation of these cells. The mechanisms regulating these changes involve the exosomal delivery of exosomal shuttle Notch1 and Rheb esRNA and component of γ-secretase complex presenilin 1 from Tsc1-null cells to wild-type cells leading to the activation of Notch and Rheb signaling in the recipient cells. The exosome-mediated mechanisms may also operate in the cells of angiomyolipoma (AML), which develops as a result of mutations in TSC1/TSC2 genes in TSC patients, because we observed the reactivation of mammalian target of rapamycin and Notch pathways, driven by the delivery of Rheb and Notch1 esRNA, in AML cells depleted of Rheb that were treated with the exosomes purified from AML cells with the constitutively high Rheb levels.

PubMed Disclaimer

Similar articles

Cited by

References

    1. EMBO Mol Med. 2011 Apr;3(4):189-200 - PubMed
    1. Cancer Cell. 2003 Aug;4(2):147-58 - PubMed
    1. Ann Neurol. 2004 Oct;56(4):478-87 - PubMed
    1. PLoS One. 2012;7(11):e50501 - PubMed
    1. Proc Natl Acad Sci U S A. 2008 Dec 9;105(49):19384-9 - PubMed

Publication types